**Question:** Episodic weakness is seen in all of the following, Except:

A. Myasthenia gravis
B. Polyneuropathy
C. Guillain-Barré syndrome
D. Botulism

**Core Concept:** Episodic weakness is a clinical presentation characterized by temporary loss of muscle strength. It can be caused by a variety of neurological disorders, including myasthenia gravis, polyneuropathy, and Guillain-Barré syndrome. These conditions share the common feature of causing weakness due to dysfunction of neuromuscular transmission or peripheral nerve dysfunction.

**Why the Correct Answer is Right:** Dysfunction in these conditions leads to muscle weakness that typically worsens with activity and improves with rest. In contrast, botulism is caused by a neurotoxin produced by the bacterium Clostridium botulinum, which targets the neuromuscular junction and leads to flaccid paralysis with fatigability but no episodic weakness.

**Why Each Wrong Option is Incorrect:**

A. Myasthenia gravis: A disorder of neuromuscular transmission caused by autoimmune attack on acetylcholine receptors, leading to episodic weakness.

B. Polyneuropathy: A condition affecting multiple peripheral nerves, causing generalized muscle weakness with sensory and motor deficits, but typically not episodic in nature.

C. Guillain-Barré syndrome: A disorder affecting peripheral nerves and motor endplates, leading to bilateral symmetrical muscle weakness, typically progressive, but not episodic.

D. Botulism: Involves neuromuscular junction dysfunction, leading to flaccid paralysis with fatigability but no episodic weakness.

**Clinical Pearl:** Botulism is a rare but serious condition that should be considered in patients presenting with progressive flaccid paralysis and fatigability, particularly in areas with high prevalence of the toxin or exposure. Prompt recognition and treatment can be crucial for patient recovery.